Document Detail


Calcium channel blockade in dialysis patients with left ventricular hypertrophy and well-preserved systolic function.
MedLine Citation:
PMID:  2455129     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Echocardiographic evidence of left ventricular hypertrophy with well-preserved systolic function was established in 4 chronic hemodialysis patients with a history of refractory pulmonary congestion. In each patient a trial of treatment with verapamil (40 mg t.i.d.) resulted in symptomatic improvement, an increase in nadir intradialysis blood pressure, and a marked reduction in intradialytic symptomatic hypertensive episodes and the need for intravenous saline administration. These data suggest that (a) a subset of chronic hemodialysis patients with refractory congestive heart failure and dialysis-related hypotension have hypertrophic cardiomyopathy with well-preserved systolic function, and (b) such patients may derive greater benefit from verapamil treatment than from the more conventional approach to drug therapy with digoxin and nitrates.
Authors:
P K Whelton; A J Watson; B Kone; N J Fortuin
Related Documents :
3100729 - The effect of mediastinal irradiation on cardiac function of patients treated during ch...
16999689 - Left and right ventricular function is impaired in behçet's disease.
3180399 - Modified fontan procedure for biventricular hearts with complex forms of double-outlet ...
7977119 - Results of biventricular endomyocardial biopsy in survivors of cardiac arrest with appa...
20810449 - Analysis of left ventricular systolic function by midwall mechanics in patients with ob...
17854389 - High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients ...
1307879 - Superior vena cava syndrome: etiology, diagnosis, and treatment.
15626959 - Clinical experience with treatment of melioidosis in children.
17584689 - Utility of t-wave alternans in congestive heart failure.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  10 Suppl 10     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1987  
Date Detail:
Created Date:  1988-08-04     Completed Date:  1988-08-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S185-6     Citation Subset:  IM    
Affiliation:
Department of Epidemiology, Johns Hopkins University School of Hygiene, Baltimore, Maryland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Blood Pressure
Body Weight
Cardiomegaly / drug therapy*,  etiology,  physiopathology
Cardiomyopathy, Dilated / drug therapy,  etiology,  physiopathology
Echocardiography
Female
Heart / anatomy & histology
Humans
Kidney Failure, Chronic / complications*,  physiopathology
Middle Aged
Renal Dialysis*
Systole
Verapamil / therapeutic use*
Chemical
Reg. No./Substance:
52-53-9/Verapamil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldip...
Next Document:  Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril.